TITLE:

EMA: FDA, European Commission and EMA reinforce collaboration to advance medicine development and evaluation

BRIEF:

 Senior leaders from the United States Food and Drug Administration (FDA), the European Commission and the European Medicines Agency (EMA) reviewed their ongoing cooperative activities and discussed strategic priorities for the next two years at their regular bilateral meeting held on 19 June 2015, at FDA Headquarters in Silver Spring, Maryland, USA.